Design, Synthesis, Biological Evaluation, and In Silico Studies of Novel Furo[2,3‐ d ]pyrimidine Derivatives as EGFR Inhibitors With Potential Antitumor Activity

Documenti analoghi

• Development of New Thiadiazole Derivatives as VEGFR‐2 Inhibitors With Anticancer and Proapoptotic Activities‏
  di: Hazem Elkady, et al.
  Pubblicazione: (2025)
• New 1,3,4‐Thiadiazole‐Based Dual B‐Raf/VEGFR‐2 Inhibitors With Potential Anti‐Breast Activity: Design, Synthesis, In Vitro and In Silico Evaluations
  di: Walid E. Elgammal, et al.
  Pubblicazione: (2025)
• Identification of Novel β ‐Lactam Derivatives as Proteasome Inhibitors for Antitumor Therapy
  di: Yu Cao, et al.
  Pubblicazione: (2025)
• Corrigendum to “Design, Synthesis, Biological Evaluation, and In Silico Studies of Quinoxaline Derivatives as Potent p38αMAPK Inhibitors”
  Pubblicazione: (2025)
• Rational Design, Green Synthesis, and Biological Evaluation of Novel Imidazole Derivatives as Potent EGFR Inhibitors via One‐Pot Four‐Component Reaction
  di: Alaa Muqbil Alsirhani, et al.
  Pubblicazione: (2025)